Background Preclinical data have suggested that nintedanib, an intracellular inhibitor of
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …

The COVID-19 pandemic has led to an unprecedented surge in hospitalised patients with
viral pneumonia. The most severely affected patients are older men, individuals of black and …

Rationale: In interstitial lung disease complicating systemic sclerosis (SSc-ILD), the optimal
prognostic use of baseline pulmonary function tests (PFTs) and high-resolution computed …

Lung cancer screening with low-dose CT can save lives. This European Union (EU) position
statement presents the available evidence and the major issues that need to be addressed …

Purpose To test the reliability of potentially new computed tomographic (CT) indicators of
pulmonary hypertension (PH) and to establish whether a combination of CT and …

Purpose: To determine whether pulmonary artery (PA) dilatation is a reliable indicator of
pulmonary hypertension (PH) in patients with pulmonary fibrosis. Materials and Methods: This …

A consistent feature of many lung nodule management guidelines is the recommendation to
evaluate nodule size by using diameter measurements and electronic calipers. Traditionally…

Rationale: Clinical and epidemiologic data in coronavirus disease (COVID-19) have accrued
rapidly since the outbreak, but few address the underlying pathophysiology. Objectives: To …

Background The INBUILD trial investigated the efficacy and safety of nintedanib versus
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …

Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for
many months. We delineated the immune-proteomic landscape in the airways and …